Tanzeum (GlaxoSmithKline LLC)
Welcome to the PulseAid listing for the Tanzeum drug offered from GlaxoSmithKline LLC. This GLP-1 Receptor Agonist [EPC],Glucagon-like Peptide-1 (GLP-1) Agonists [MoA] pharmaceutical is classified as a HUMAN PRESCRIPTION DRUG. Below, you can view details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same HUMAN PRESCRIPTION DRUG drug type category.
LABELER NAME / MANUFACTURER: | GlaxoSmithKline LLC |
NON-PROPRIETARY NAME: | albiglutide |
SUBSTANCE NAME: | ALBIGLUTIDE |
TYPE: | HUMAN PRESCRIPTION DRUG |
PHARMA CLASS: | GLP-1 Receptor Agonist [EPC],Glucagon-like Peptide-1 (GLP-1) Agonists [MoA] |
ROUTE: | SUBCUTANEOUS |
DOSAGE FORM: | INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION |
MARKETING CATEGORY NAME: | BLA |
START MARKETING DATE: | 2014-04-15 |
END MARKETING DATE: | 0000-00-00 |
Tanzeum HUMAN PRESCRIPTION DRUG Details:
Item Description | Tanzeum from GlaxoSmithKline LLC |
LABELER NAME: | GlaxoSmithKline LLC |
DEA SCHEDULE: |
|
ACTIVE STRENGTH: | 30(mg/.5mL) |
START MARKETING DATE: | 2014-04-15 |
END MARKETING DATE: | 0000-00-00 |
PRODUCT ID: | 0173-0866_330e923a-4667-456a-b240-d06efd7f7378 |
PRODUCT NDC: | 0173-0866 |
APPLICATION NUMBER: | BLA125431 |
Other ALBIGLUTIDE Pharmaceutical Manufacturers / Labelers: